Mark Bodmer - 07 Feb 2023 Form 4 Insider Report for Evelo Biosciences, Inc.

Role
CSO, President of R&D
Signature
/s/ Dominic V. Capasso, Attorney-in-Fact for Mark Bodmer
Issuer symbol
EVLO on OTC
Transactions as of
07 Feb 2023
Net transactions value
$0
Form type
4
Filing time
09 Feb 2023, 15:32:51 UTC
Previous filing
21 Jan 2022
Next filing
09 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EVLO Restricted Stock Units Award $0 +530,000 $0.000000 530,000 07 Feb 2023 Common Stock 530,000 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Restricted Stock Units vest in four (4) substantially equal quarterly installments following the February 07, 2023 grant date, such that all of the Restricted Stock Units will become vested on the first anniversary of the grant date, subject to the reporting person's continued service to the issuer on each such vesting date.